Compounds > beta-d-galactopyranosylmethyl-4-nitrophenyltriazene
Page last updated: 2024-09-04

beta-d-galactopyranosylmethyl-4-nitrophenyltriazene and Ganglioside Storage Diseases

beta-d-galactopyranosylmethyl-4-nitrophenyltriazene has been researched along with Ganglioside Storage Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singer, HS; Sinnott, ML; Slesinger, PA; Tiemeyer, M1

Other Studies

1 other study(ies) available for beta-d-galactopyranosylmethyl-4-nitrophenyltriazene and Ganglioside Storage Diseases

ArticleYear
Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Annals of neurology, 1987, Volume: 21, Issue:5

    Topics: beta-Galactosidase; Brain; Brain Diseases, Metabolic; G(M1) Ganglioside; Galactosidases; Gangliosidoses; Humans; Inclusion Bodies; Lysosomes; Triazenes

1987